INTEGRA LIFESCIENCES HOLDINGS CORP (IART) FY2026 Q2 Statement of Cash Flows

Statement of Cash Flows

2026-04-01 to 2026-06-30

Swipe to see the full flow
INTEGRA LIFESCIENCES HOLDINGS CORP cash flow reconciliation, Apr 1, 2026 through Jun 30, 2026One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Orange marks positive customer-advance and deferred-revenue changes that add to operating cash in the reconciliation. These are net changes, not gross customer receipts. Negative changes are neutral reconciliation adjustments; they do not by themselves identify cash payments. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Net loss → Net cash from operating activities: $4,483,000.00Depreciation and amortization → Operating adjustments reconciliation: $38,135,000.00Share-based compensation → Operating adjustments reconciliation: $5,844,000.00Non-cash lease adjustment → Operating adjustments reconciliation: $2,618,000.00Amortization of debt issuance costs and expenses associated with debt refinancing → Operating adjustments reconciliation: $1,020,000.00Other non-current liabilities → Operating adjustments reconciliation: $836,000.00Loss on disposal of property and equipment → Operating adjustments reconciliation: $643,000.00Change in fair value of contingent consideration and others → Operating adjustments reconciliation: $519,000.00Inventories → Operating adjustments reconciliation: $474,000.00Operating adjustments reconciliation → Net cash from operating activities: $18,319,000.00Operating adjustments reconciliation → Accounts payable, accrued expenses and other current liabilities: $15,198,000.00Operating adjustments reconciliation → Prepaid expenses and other current assets: $7,440,000.00Operating adjustments reconciliation → Deferred income tax provision (benefit): $4,333,000.00Operating adjustments reconciliation → Accounts receivable: $3,041,000.00Operating adjustments reconciliation → Other non-current assets: $996,000.00Operating adjustments reconciliation → Contract liabilities: $762,000.00Net cash used in investing activities → investing reconciliation: $43,283,000.00investing reconciliation → Purchases of short-term investments: $30,976,000.00investing reconciliation → Purchases of property and equipment: $12,307,000.00Net cash used in financing activities → financing reconciliation: $818,000.00Proceeds from borrowings of long-term indebtedness → financing reconciliation: $31,400,000.00financing reconciliation → Payments on debt: $24,887,000.00financing reconciliation → Payments for contingent considerations: $6,842,000.00financing reconciliation → Payment of debt issuance costs: $275,000.00financing reconciliation → Cash taxes paid in net equity settlement: $214,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $236,809,000.00Net cash from operating activities → Cash sources and uses: $22,802,000.00Cash sources and uses → Exchange-rate effect: $1,095,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $214,415,000.00Cash sources and uses → Net cash used in investing activities: $43,283,000.00Cash sources and uses → Net cash used in financing activities: $818,000.00Net loss: $4,483,000.00Net loss+$4.48 MDepreciation and amortization: $38,135,000.00Other D&A+$38.14 MDeferred income tax provision (benefit): -$4,333,000.00Deferred income taxes−$4.33 MShare-based compensation: $5,844,000.00Stock-based compensation+$5.84 MAmortization of debt issuance costs and expenses associated with debt refinancing: $1,020,000.00Debt cost & refinancing amort.+$1.02 MNon-cash lease adjustment: $2,618,000.00Non-cash lease adjustment+$2.62 MLoss on disposal of property and equipment: $643,000.00PP&E disposal gain & loss+$643.00 KChange in fair value of contingent consideration and others: $519,000.00Contingent consideration change+$519.00 KAccounts receivable: -$3,041,000.00Accounts receivable−$3.04 MInventories: $474,000.00Inventories+$474.00 KPrepaid expenses and other current assets: -$7,440,000.00Prepaid & other assets−$7.44 MOther non-current assets: -$996,000.00Other operating assets−$996.00 KAccounts payable, accrued expenses and other current liabilities: -$15,198,000.00Payables & accrued liabilities−$15.20 MContract liabilities: -$762,000.00Deferred revenue−$762.00 KOther non-current liabilities: $836,000.00Other noncurrent liabilities+$836.00 KNon-cash impairment charges: $0.00Net cash from operating activities: $22,802,000.00Operating cash+$22.80 MOperating adjustments reconciliation: $50,089,000.00Proceeds from borrowings of long-term indebtedness: $31,400,000.00Secured debt issued+$31.40 MPayments on debt: -$24,887,000.00Secured debt repaid−$24.89 MPayments for contingent considerations: -$6,842,000.00Contingent consideration paid−$6.84 MProceeds from exercised stock options and employee stock purchase plan: $0.00Cash taxes paid in net equity settlement: -$214,000.00Stock-award tax withholding−$214.00 KPurchases of treasury stock: $0.00Payment of debt issuance costs: -$275,000.00Debt issuance costs−$275.00 KNet cash used in financing activities: -$818,000.00. Cash required to fund net payments.Financing cash−$818.00 Kfinancing reconciliation: $32,218,000.00Purchases of property and equipment: -$12,307,000.00PP&E purchases−$12.31 MPurchases of short-term investments: -$30,976,000.00Investment purchases−$30.98 MNet cash used in investing activities: -$43,283,000.00. Cash required to fund net payments.Investing cash−$43.28 Minvesting reconciliation: $43,283,000.00Cash sources and uses: $259,611,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $236,809,000.00Beginning cash$236.81 MEnding cash: Cash, cash equivalents, and restricted cash: $214,415,000.00Ending cash$214.42 MExchange-rate effect: -$1,095,000.00FX effect−$1.10 MCASH RECONCILIATIONOperatingflowsInvestingflowsFinancingflowsFree cash flow$10.50 MOperating cash − cash spent on PP&ECash flow / Net income5.09×Operating cash flow ÷ net incomeNet cash change−$22.39 MEnding cash − beginning cash
Chart details

INTEGRA LIFESCIENCES HOLDINGS CORP cash flow reconciliation, Apr 1, 2026 through Jun 30, 2026

Cash flows for Apr 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Mar 31, 2026. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Mar 31, 2026
236,809,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
22,802,000 US dollars. Net cash provided.
Net loss
4,483,000 US dollars
Depreciation and amortization
38,135,000 US dollars
Deferred income tax provision (benefit)
negative 4,333,000 US dollars
Share-based compensation
5,844,000 US dollars
Amortization of debt issuance costs and expenses associated with debt refinancing
1,020,000 US dollars
Non-cash lease adjustment
2,618,000 US dollars
Loss on disposal of property and equipment
643,000 US dollars
Change in fair value of contingent consideration and others
519,000 US dollars
Accounts receivable
negative 3,041,000 US dollars
Inventories
474,000 US dollars
Prepaid expenses and other current assets
negative 7,440,000 US dollars
Other non-current assets
negative 996,000 US dollars
Accounts payable, accrued expenses and other current liabilities
negative 15,198,000 US dollars
Contract liabilities
negative 762,000 US dollars
Other non-current liabilities
836,000 US dollars
Non-cash impairment charges
0 US dollars
Investing activities
negative 43,283,000 US dollars. Net cash used.
Purchases of property and equipment
negative 12,307,000 US dollars
Purchases of short-term investments
negative 30,976,000 US dollars
Financing activities
negative 818,000 US dollars. Net cash used.
Proceeds from borrowings of long-term indebtedness
31,400,000 US dollars
Payments on debt
negative 24,887,000 US dollars
Payments for contingent considerations
negative 6,842,000 US dollars
Proceeds from exercised stock options and employee stock purchase plan
0 US dollars
Cash taxes paid in net equity settlement
negative 214,000 US dollars
Purchases of treasury stock
0 US dollars
Payment of debt issuance costs
negative 275,000 US dollars
Operating adjustment reconciliation
50,089,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
32,218,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
43,283,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
negative 1,095,000 US dollars
Ending cash on Jun 30, 2026
214,415,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
259,611,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
negative 22,394,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
5.09×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
Operating cash flow
22,802,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
12,307,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
10,495,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income enters operating cash directly in the reconciliation. The adjustment junction contributes the remaining $18.32M after reconciling the other positive and negative adjustments. These connections depict an accounting reconciliation, not traced cash receipts.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Cash-flow net income is $4,483.00 K, derived by subtracting the earlier cumulative period; the income statement reports $4,482.00 K for the same period. The $1.00 K difference is rounding: the filing reports each amount rounded to the nearest thousand dollars, and the quarter is the difference of two rounded year-to-date amounts. Neither amount has been adjusted.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 22,802,000 US dollars minus 12,307,000 US dollars equals 10,495,000 US dollars.
  • Cash-flow net income is $4,483.00 K, derived by subtracting the earlier cumulative period; the income statement reports $4,482.00 K for the same period. The $1.00 K difference is rounding: the filing reports each amount rounded to the nearest thousand dollars, and the quarter is the difference of two rounded year-to-date amounts. Neither amount has been adjusted.
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) FY2026 Q2 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!